Biosurgery Global Market By Product Type, By Application, By Source, By End User, Opportunity Analysis and Industry Forecast, 2024-2033
The Biosurgery by The
Business Research Company provides market overview across 60+ geographies in
the seven regions - Asia-Pacific, Western Europe, Eastern Europe, North
America, South America, the Middle East, and Africa, encompassing 27 major
global industries. The report presents a comprehensive analysis over a ten-year
historic period (2010-2021) and extends its insights into a ten-year forecast
period (2023-2033).
Learn More On The Biosurgery Market:
https://www.thebusinessresearchcompany.com/report/biosurgery-global-market-report
According to The Business Research Company’s Biosurgery, the biosurgery market
size has grown strongly in recent years. It will grow from $14.01 billion in
2023 to $15.18 billion in 2024 at a compound annual growth rate (CAGR) of
8.4%. The growth in the historic period
can be attributed to increasing surgical procedures, rise in chronic diseases,
growing geriatric population, shift towards biodegradable product, regulatory
changes and approvals.
The biosurgery market size is expected to see strong growth in the next few
years. It will grow to $20.87 billion in 2028 at a compound annual growth rate
(CAGR) of 8.3%. The growth in the
forecast period can be attributed to advancements in tissue engineering, rise
in minimally invasive procedures, focus on regenerative medicine, shift towards
biologics, aging population needs. Major trends in the forecast period include
growth in minimally invasive procedures, rise in cosmetic and plastic
surgeries, focus on stem cell therapies, advancements in wound care,
development of biodegradable products..
The increase in the prevalence of chronic disease is expected to propel the
growth of the biosurgery market going forward. Chronic disease refers to health
problems that persist for a year or longer and necessitate continuing medical
care, restricting everyday activities, or both. The main causes of death and
disability in the US are chronic diseases such as diabetes, cancer, and heart
disease. Biosurgery is used to eliminate dead tissue, lower the risk of
infection, and speed up the healing process for chronic wounds. For instance,
in March 2022, according to the Australian Bureau of Statistics, an
Australia-based self-contained legal agency responsible for collecting and
analyzing data as well as making evidence-based recommendations to federal,
state, and territory governments, seventy-eight percent (78.6%) of Australians
suffered from at least one chronic illness. 11.6 million individuals, or over
half of the population, suffered from at least one chronic illness. Therefore,
the increase in the prevalence of chronic disease is driving the growth of the
biosurgery market.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=9380&type=smp
The biosurgery market covered in this report is segmented –
1) By Product: Bone-Graft Substitutes, Soft-Tissue Attachments, Hemostatic
Agents, Surgical Sealants and Adhesives, Adhesion Barriers, Staple Line
Reinforcement
2) By Source: Natural or Biologics Products, Synthetic Products
3) By Application: Orthopedic Surgery, General Surgery, Neurological Surgery,
Cardiovascular Surgery, Gynecological Surgery, Other Applications
4) By End-User: Hospitals, Clinics, Other End-Users
Product innovations have emerged as the key trend gaining popularity in the
biosurgery market. Major companies operating in the biosurgery market are
developing product innovations to strengthen their position in the market. For
instance, in April 2021, Aroa Biosurgery, a New Zealand-based manufacturer of
medical and surgical products, launched Myriad Morcells, a Myriad Matrix
morcellized (powder) configuration that easily adapts to improve interaction
with uneven wound beds. It provides a burst of biologically significant ECM
proteins in a format that fits the specifics of a wound in order to 'kick
start' healing. A multi-layered extracellular matrix (ECM) graft with a high volume
and surface area that has interstitial spaces that are quickly and easily
accessible to cells is called Myriad Matrix. It makes use of the Aroa ECM
bioscaffold technology, which incorporates crucial secondary chemicals and
lingering vascular channels to assist the formation of new tissue.
The biosurgery market report table of contents includes:
1. Executive Summary
2. Biosurgery Market
Characteristics
3. Biosurgery Market Trends
And Strategies
4. Biosurgery Market -
Macro Economic Scenario
5. Global Biosurgery Market
Size and Growth
.
.
.
31. Global Biosurgery
Market Competitive Benchmarking
32. Global Biosurgery
Market Competitive Dashboard
33. Key Mergers And
Acquisitions In The Biosurgery Market
34. Biosurgery Market
Future Outlook and Potential Analysis
35. Appendix
Related Reports
https://topprnews.com/automotive-finance-market-growth
https://topprnews.com/automotive-human-machine-interfaces-market
https://topprnews.com/automotive-intelligence-battery-sensor-market
https://goodprnews.com/automotive-finance-market-growth
https://goodprnews.com/automotive-human-machine-interfaces-market
https://goodprnews.com/automotive-intelligence-battery-sensor-market
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Comments
Post a Comment